8-Chloroquinolin-6-ol

Catalog No.: 
ACPVEL605
CAS No.: 
18119-24-9
Molecular Formula: 
C9H6ClNO
Molecular Weight: 
179.61
8-Chloroquinolin-6-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$64.00In stockIn stock
25g97%$318.00In stockIn stock
100g97%$1174.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Chloroquinolin-6-ol
IUPAC Name8-chloroquinolin-6-ol
MDL No.MFCD09951943
Molecular FormulaC9H6ClNO
Molecular Weight179.61
SMILESOC1=CC(Cl)=C2N=CC=CC2=C1
InChI KeyNSFZSTFINAEFAB-UHFFFAOYSA-N
Synonym8-CHLOROQUINOLIN-6-OL | 18119-24-9 | 8-Chloro-6-hydroxyquinoline | 6-Quinolinol, 8-chloro- | MFCD09951943 | SCHEMBL3565423 | DTXSID50609426 | NSFZSTFINAEFAB-UHFFFAOYSA-N | SMSSF-0625465 | AKOS006314115 | SB68138 | AMS_CNC_ID-1762297630 | DS-11478 | SY041629 | CS-0029519
CAS No.18119-24-9
PubChem CID20701169

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPVEL605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLOGE834 route compound structure diagram
    ACLOGE83417609-80-2In Stock
  2. Then
  3. ACPVEL605 route product structure diagram
    ACPVEL60518119-24-9In Stock
Inquiry

2. ACPVEL605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLOGE834 route compound structure diagram
    ACLOGE83417609-80-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPVEL605 route product structure diagram
    ACPVEL60518119-24-9In Stock
Inquiry

3. ACPVEL605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIMBC328 route compound structure diagram
    ACIMBC328796851-15-5In Stock
  2. Then
  3. ACPVEL605 route product structure diagram
    ACPVEL60518119-24-9In Stock
Inquiry

Comments (0)